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Abstract: Linseed - also known as flaxseed - is known for its beneficial effects on animal 
health attributed to its composition. Linseed comprises linoleic and α-linolenic fatty acids, 
various dietary fibers and lignans, which are beneficial to health because they reduce the risk 
of cardiovascular diseases, as well as cancer, decreasing the levels of cholesterol and relaxing 
the smooth muscle cells in arteries increasing the blood flow. Essential fatty acids from flax 
participate in several metabolic processes of the cell, not only as structuring components of 
the cell membrane but also as storage lipids. Flax, being considered a functional food, can be 
consumed in a variety of ways, including seeds, oil or flour, contributing to basic nutrition. 
Several formulations containing flax are available on the market in the form of e.g. capsules 
and microencapsulated powders having potential as nutraceuticals. This paper revises the dif-
ferent lipid classes found in flaxseeds and their genomics. It also discusses the beneficial ef-
fects of flax and flaxseed oil and their biological advantages as ingredients in pharmaceuticals 
and in nutraceuticals products. 
Keywords: Linseed, flaxseed, nutraceuticals, pharmaceuticals, essential fatty acids, linseed essential oil. 
1. INTRODUCTION 
In the last few years, due to the increased con-
sumer’s interest in the relationship between diet and 
health, functional foods, dietary supplements and 
nutraceuticals have been receiving particular attention, 
and their market is increasing rapidly. One of the most 
promising bioactive molecules are the phytochemicals 
from plants [1]. A variety of functional foods and die-
tary supplements has been introduced to the market,  
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and many have recognised the potential for beneficial 
effect on human health [2]. A diet where omega-3 fatty 
acids (FAs) are present in abundance brings many posi-
tive effects, which have contributed to the investment 
in research in this field  [3]. Flax, a multi-purpose crop, 
has been applied in industrial and food uses [4]. Flax-
seed can be used for medicinal purposes and as a 
nutritional product, and it can also be used for fiber and 
oil, being cultivated in various regions [1]. When lin-
seed oil is drawn from seeds, it can be applied in 
varnishes, stains, manufacturing of paints as well as 
linoleum flooring, which are eco-friendly. In food 
products and also in nutraceuticals, flax seeds are very 
popular [4]. As a crucial functional food ingredient, 
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interest in flaxseed is growing, mainly due to the essen-
tial fatty acids (EFAs) that comprise omega-3 (C18:3; 
α-linolenic; ALA) and omega-6 (C18:2; linoleic) fatty 
acids, dietary fibres and lignans. Flax EFAs exhibit 
structural and storage functions. Condensing and de-
saturation enzymes that are located in plastids, while 
endoplasmic reticulum is responsible for catalysis of 
FA biosynthesis in oilseeds. Cutin and suberin produc-
tion, storage lipid synthesis in developing seeds and 
also cuticular wax layer synthesis in distinct tissue 
types as well as developmental stages, are examples of 
various metabolic pathways where free FAs are im-
plied. A thorough understanding of these multiple as-
pects of flax lipids is essential for the development of 
strategies to modify such essential metabolic compo-
nents [4]. There are many health advantages of using 
linseed oil, flax fibers and lignans, among them, the 
reduction of autoimmune and neurological disorders, 
osteoporosis and atherosclerosis as well as arthritis, 
cancer, diabetes and also decreasing the risk of cardio-
vascular disease [5]. 
This manuscript revises the different lipid classes 
found in flaxseeds and their genomics, highlighting the 
benefits of the use of flax and flaxseed oil as compo-
nents of pharmaceutical and nutraceutical formulations. 
2. BIOCHEMISTRY 
2.1. Lipids 
In the constitution of lipids, FAs and their deriva-
tives as well as substances that are related to them, ei-
ther functionally or biosynthetically, are usually pre-
sent. They are important forms of carbon storage in 
plant seeds and in cellular membranes [6]. Through an 
FA synthase complex, the FAs (natural compounds) are 
synthesized by condensation of malonyl CoA units. 
Commonly, they have even numbers of carbon atoms 
in straight chains, which can contain varied substituent 
groups and these chains are saturated or unsaturated. 
Generally, lipids can dissolve rapidly in organic sol-
vents, including alcohols, chloroform, benzene, as well 
as ethers. In the plant, flax lipids are found in their dif-
ferent parts in form of free FAs, triacylglycerols 
(TAGs), oxylipins, waxes and many other lipophilic 
compounds [7]. Lipids have vital physiological func-
tions, as in seed germination, desiccation [8-10], in the 
structural integrity of cell, tissues and organs [11]and 
in the protection against biotic and abiotic stresses [12]. 
2.1.1. Classes of Lipids 
A growing number of lipids are expected to be de-
scribed with the dawn of the lipidomics era. In 2005, a 
Lipids Metabolites and Pathways Strategy (LIPIDS 
MAPS) was developed, a new system that classifies 
them [13]. For classification purposes, lipids have been 
considered hydrophobic or amphipathic small mole-
cules originating from carbanion-based condensations 
of thioesters and from carbocation-based condensations 
of isoprene units, being separated in simple lipids that 
produce up to two types of products on hydrolysis and 
also complex lipids that produce more than three prod-
ucts on hydrolysis [4, 13]. According to this system, 
lipids can be classified into eight categories, such as 
fatty acyls, glycerolipids, glycerophospholipids, sphin-
golipids, sterol lipids, prenol lipids, saccharolipids as 
well as polyketides [13, 14]. Seed storage lipids are 
more attractive targets for metabolic engineering, once 
they are less likely to disturb the physiology of the 
plant, also representing the major lipids used in food 
and non-food applications.  
Fatty acyl and glycerolipid classes are the most 
prevalent lipid forms in flax seeds [4]. One of the most 
important categories of biological lipids is the fatty 
acyls that are also the main lipid building block of 
complex lipids [13]. In this category, there are FA sub-
classes, such as straight-chain saturated and unsatu-
rated FAs, hydroperoxy FAs, hydroxy FAs and epoxy 
FAs, all representing biologically active lipid com-
pounds either for food or for industrial purposes. Many 
of these FAs have been reported in different parts of 
flax plants where they play major roles in several plant 
developmental processes [4]. Seed storage lipids are 
found usually in the form of glycerolipids [9] and they 
are identified as mono-, di- and triacylglycerols in flax 
seed oil. The TAGs account for the highest proportion 
of neutral lipids, representing up to 30% of fresh seed 
weight while monoglycerols account for 0.34%, dia-
cylglycerols for 0.64% and free FAs for 0.42% [15]. 
There are more than 20 TAGs identified from linseed 
oil samples that are composed of C18:3, C18:2, C18:1 
(oleic acid) moieties and also of C18:0 (stearic acid) 
and C16:0 (palmitic acid) moieties. The FA composi-
tion of TAGs is strongly determined by genotypes and 
environment [4]. 
2.1.2. Dietary Use of Lipids and Flaxseed 
Due to dwindling fish resources and the high cost of 
extraction from marine microalga, there is increased 
search for nutritionally important omega-3 FAs 
namely, ALA (C18:39, 12, 15), eicosapentaenoic acid 
(C20:55,8,11,14,17; EPA) and docosahexaenoic acid 
(C22:64,7,10,13,16,19; DHA) [16]. C18 FAs (on their 
own and upon elongation to EPA and DHA) play a 
crucial role as membrane phospholipids, especially in 
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the brain, the fetal neuronal system and in cardiovascu-
lar health. There is no possibility to synthesize C18 
FAs, hence omega-3 FAs must be supplemented 
through diet [17]. One of the richest vegetal sources of 
omega-3 fatty acids is the flaxseed, therefore dietary 
intake of flax seed/oil represents an excellent source of 
ALA [18]. Linoleic and linolenic acids function as sub-
strates for further elongation to produce arachidonic 
acid (C20:4,5,8,11,14;ARA; omega-6 FA), EPA and 
DHA. Flaxseed oil is composed of saturated fatty acids, 
monosaturated fatty acids and polyunsaturated fatty 
acids, in a percentage of 9 %, 18 % and 73 %, 
respectively [19]. The main fatty acid that is α-linolenic 
acid, varying over a range of 39-60 % followed by 
oleic, linoleic, palmitic and stearic acids [20]. Flaxseed 
oil is rich in anti-oxidants, including tocopherols and 
also betacarotene, but it is readily oxidized after being 
extracted and purified. The bioavailability of ALA is 
higher in oil, followed by the milled seed, and then the 
whole seed [5]. 
2.2. Linseed Oil and Protein Characteristics 
Flaxseed makes meals richer in protein because of 
its fatty acid composition and oil content, which con-
tributes to the high growth rate of oilseeds worldwide. 
However, for human use, flaxseed has not yet been in-
vestigated as a source of protein. It is well known that 
industry is looking for food protein ingredient based on 
plants as an alternative to animal-derived ingredients 
[21]. 
Flaxseed contains about 41% oil and its protein con-
tent ranges between 20-30 %, being nearly 80 % of 
globulins (linin and conlinin) and 20 % of glutelin but 
these can vary according to seeding and growing condi-
tions. Oil, being a main component of flaxseed, con-
tains various fatty acids, among which stearic acid 
(18:0) (3%), palmitic acid (16:0) (5%), linoleic acid 
(18:2n-6) (15%), oleic acid (18:1n-9) (17%) as well as 
ALA (18:3n-3) (59%), but between seeds when envi-
ronmental factors are equivalent, these concentrations 
may also vary [22]. Flaxseed has limited amino acid 
lysine content, the reason why it is not a complete pro-
tein; in comparison to soybean, flaxseed has a similar 
amino acid profile and does not contain gluten. It is a 
rich source of glutamic acid/glutamine, arginine and 
branched-chain amino acids (valine and leucine) as 
well as aromatic amino acid (tyrosine and phenyla-
lanine). Flaxseed has a nitrogen content of 3.25 g/100 g 
of seed. Oil is the primary product obtained from flax-
seed but contains only about 21% protein while resid-
ual paste can be applied in the production of animal 
feed and has about 34% protein. In order to achieve a 
product with high protein content and advantageous 
functional characteristics, the flaxseed paste can be 
converted into protein concentrate and can be used in 
conventional foods [5]. Albumins and globulins are the 
main storage of proteins of flaxseed and can be 
classified according to their solubility in aqueous sol-
vents. In the total content of protein flaxseed, globulins 
are about 58-66% and albumin is about 20% [23]. The 
protein secondary structure profile of globulin storage 
protein constitutes 3% α-helix, 17% β-sheet and 80% is 
aperiodic whereas the albumin constitutes26% α-helix, 
32% β-sheet and also 42% aperiodic [24].Thus, taking 
into account these secondary structure profiles, it is 
obvious that the β-sheet is the predominant secondary 
structure in flaxseed protein. In the flaxseed, another 
crucial protein group - oleosins – can be found 
composing about 2-8% of total protein in oilseeds, and 
their function is oil storage. The activity of these oil 
storage proteins is due to an elongated and anti-parallel 
β-sheet which has a large number of hydrophobic resi-
dues, composing nearly 30 % protein e.g. peanuts. 
Oleosins are required to form the oil bodies. The am-
phipathic character of these proteins controls the 
oil/protein matrix of flaxseed that is important in pro-
tein and fat digestibility [25]. Flaxseed proteins are be-
ing studied also for their emulsifying properties [26, 
27]. When compared to soybean protein, crude flax-
seed protein that has flaxseed mucilage exhibits higher 
water absorption and oil absorption, as well as emulsi-
fying activity [28, 29]. Karaca et al. showed that com-
pared to whey protein isolates (WPI)-stabilized emul-
sions (90.8%), the creaming stability of emulsions 
(96.6%) stabilized by flaxseed proteins was similar 
[21]. At pH 6, flax protein concentrate has shown bet-
ter oil absorption capacity (150.25%) as well as water 
absorption capacity (253.5%), high foam stability 
(83.33%), emulsifying activity (88.37%) and also 
emulsifying capacity (84.76 mL/g), which is crucial for 
the use of this protein concentrate in various products, 
including bread products, hamburgers and also salad 
dressings or mayonnaise [30,31]. 
2.3. Polyunsaturated Fatty Acids 
The structures of the polyunsaturated fatty acids 
(PUFAs), omega-3 and omega-6 FAs are used to 
classify them. PUFAs are crucial because humans do 
not have desaturases and then they should get them by 
dietary supplementation [3]. Alpha-linoleic acid is en-
zymatically divided into eicosapentaenoic acid and 
docosahexaenoic acid, being precursors of many pros-
taglandins, thromboxanes as well as leukotrienes. Lino-
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leic acid, as well as arachidonic acid, allows the pro-
duction of eicosanoids, exhibiting proinflammatory and 
also prothrombic effects [32]. In the past, the consump-
tion of omega-6 and omega-3 was in the ratio of 1 to 
2:1, but nowadays, it increased up to the ratio of 20:1 
with a ingestion of alpha-linoleic acid of less than 1 g/d 
in the western diet [33, 34]. This huge difference in the 
amount of omega-6 FAs in comparison to omega-3 
FAs is mainly because of the modification of agricul-
ture, as well as cooking practices [35]. Due to this pro-
portion of FAs, in the last years, there has been an in-
crease of health claims, the dietary proportion can con-
trol the consequence of inflammatory responses to de-
pression and also stress in humans [3]. Several works 
have reported that omega-3 PUFAs avoid oxidative 
damage and allow the regulation of neurotrophic factor 
levels after traumatic brain lesion [36]. Other works 
have demonstrated that omega-3 PUFAs can decrease 
the risk of various disorders, including atherosclerosis, 
atrial fibrillation and sudden cardiac death, as well as 
coronary heart disease [37-39]. 
Table 1. Major fatty acids profile of flaxseed (Adapted 
from [1, 5]). 




Palmitic acid (C16:0)	 4.90–8.00 
Stearic acid (C18:0)	 2.24–4.59 
Oleic acid (C18:1)	 13.44–19.39 
Linoleic acid (omega-6, C18:2) 12.25 – 17.44 
Alpha-linolenic acid (omega-3, C18:3) 39.90 – 60.42 
Ratio omega-6/omega-3 0.3 
3. FLAXSEED AND LINSEED ESSENTIAL OIL 
Flax, a blue flowering annual herb, is characterized 
by golden yellow to reddish brown color flat seeds. It is 
a member of family Lineaceae of Latin name “Linum 
usitatissimum” (i.e. “very useful”) and each of its par-
ties can be used commercially (after processing or even 
directly) [1, 40]. 
Flaxseed or linseed are different terms that can be 
applied as synonymous, i.e. it is called flaxseed when it 
is for human usage, and linseed when it is for industrial 
applications [40-42]. Nowadays, it is planted in many 
countries, with an emphasis in the Northern hemi-
sphere, being China, United States and Canada, as well 
as India and Ethiopia the higher producers. Among 
these, Canada is the largest producer and exporter 
worldwide, with about 80 % of world trade in flaxseed 
[5, 40, 43-45]. Flaxseed, an edible oilseed, possesses a 
crispy texture and nutty taste [41, 46]. Its interest is 
increasing as functional food, mainly due to the richest 
vegetable source of ALA and lignans (class of phytoes-
trogen), with a percentage of 50%–62% of flaxseed oil 
or 22% of whole flaxseed and a range of 0.2–13.3 mg/g 
flaxseed, respectively. About 28% of flaxseed is com-
posed of dietary fibers, among which about one-third is 
soluble fiber [18, 40, 47, 48]. In its composition figure 
enterolignan precursors, primarily secoisolariciresinol 
diglucoside (SDG), fibers, ALA and also omega-3 FAs 
[49, 50]. 
Flaxseeds are available in brown and yellow or 
golden varieties with the same nutritional attributes and 
also amount FAs. However, there is a special case 
which is solin -also known as Linola-, a type of yellow 
flax with a distinct oil profile and low levels of omega-
3 FAs [51]. Brown flax is known as one ingredient of 
cattle feed and fibers, as well as varnish or paints. It is 
also available in the food market in various edible 
forms of flax, such as flax oil and roasted flax or milled 
flax and whole flaxseeds [5]. Through the distinct per-
centage of compounds, the different varieties of flax-
seed can be used for a set of health effects [52]. 
Epaminondas et al. demonstrated some differences in 
both varieties of flaxseed, i.e. in the golden flaxseed 
there is less quantity of fiber and higher quantity of 
soluble carbohydrates but no differences have been 
found in the quantity of lipids and proteins [53]. Sargi 
et al. demonstrated that golden flaxseed has a higher 
amount of omega-3 and omega-6 while brown flaxseed 
has higher antioxidant capacity [54]. Attributed to these 
properties, the interest of flaxseed in the food sector is 
being steadily increasing [5]. 
3.1. Form and Morphology of Flaxseed 
Commercial flaxseed varieties are different in size 
and also in color. They have about 2.5 mm wide and 5 
mm long, as well as 1.5 mm thick [55, 56]. The seed is 
composed of mucilage (epiderm), seed coat, as well as 
the layer of endosperm surrounding two cotyledons. It 
is known that the endosperm and also the cotyledons 
contain distinct oil compositions as well as soluble pro-
tein [55, 57, 58]. In the flaxseed aleurone cells are 
found disposed of by the endosperm and cotyledons, 
where the shape of its grains is different [55, 59]. The 
oil, on the other hand, is disposed of by the endosperm 
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and cotyledons and are present as microscopic droplets 
[55, 56]. 
3.2. Functional Elements of Flaxseed 
Due to its bioactive components, i.e. alpha-linolenic 
acid, lignans and dietary fibers as well as minerals, 
flaxseed can be considered as a functional food [1, 5]. 
Apart from these elements, flaxseed also contains vi-
tamins (A, C, F and E), minerals (P, Mg, K, Na, Fe, 
Cu, Mn and Zn), soluble polysaccharides and phenolic 
compounds [5, 22, 60]. It also exhibits a high level of 
calcium, magnesium and also phosphorus, thus when a 
portion of 30 g is consumed it corresponds to 7-30 % 
of the recommended dietary allowances (RDAs)  [61].  
3.2.1. Alpha-Linolenic Acid 
The essential element of flaxseed is alpha-linolenic 
acid, containing ca. 73% of polyunsaturated fatty 
acid,18% of monounsaturated fat, and 9% of saturated 
fat [62, 63]. Fatty acids - also known as essential acids 
- are necessary for the human body and are supplied by 
food since the body has no way of producing them 
[64].  
In the case of omega-3, the human body cannot add 
a double bond beyond the ninth carbon from carboxyl 
end of FA. The originator of the synthesis of polyun-
saturated fatty acids (EPA and DHA) is ALA, but they 
can also be metabolized to eicosanoids, prostaglandins 
and also leukotrienes by the enzymes cyclooxygenase 
and lipoxygenase. During this transformation, many 
fatty acids are synthesized through the desaturation and 
elongation reactions with the help of specific desatu-
rases and elongases. It was shown that the synthesis of 
linolenic acid also occurs with the same enzymatic re-
actions. However, the conversion of ALA into EPA 
and also DHA is not competent in humans and animals, 
leading to a competition between them for the same 
enzymes. Mammals do not have these enzymatic ac-
tivities but lower order animals have such activities, 
although recent studies point out that mice have these 
enzymes and can transform omega-6 fatty acid to 
omega-3 fatty acid. In the human diet, a balanced in-
take of omega-3 and omega-6 essential fatty acids is 
therefore recommended [1, 65-67]. Both these essential 
fatty acids look for location within cell membranes. If 
there is an imbalance of one type of fatty acid, the pre-
dominant will be assimilated into the cell membrane, 
inducing adverse effects in the fluidity of membrane 
leading to changes of cellular functions. On the other 
hand, if there is a balance of these fatty acids, the 
omega-3 fatty acid is preferred over the other. It is 
known that the influence of these fatty acids on the 
physiological functions is opposite [1, 66, 68]. EPA 
and DHA are transformed into resolvins, 
neuroprotection and also protectins. Resolvins are effi-
cient anti-inflammatory mediators, circumventing in-
flammation by inhibiting the work of prostanoids. To 
control the homeostasis, resolvins and protectins con-
tribute to the elimination in gastrointestinal, kidney, 
oral, skin, lung, among other inflammations through 
the activation of special mechanisms. DHA, trans-
formed into neuroprotectins, show neuroprotective ef-
fects. A balance between fatty acids is therefore essen-
tial in order to maintain good health [1, 69, 70]. 
The proportion of omega-6 to omega-3 fatty acid is 
currently being estimated as 38–50:1 in Indian diets 
and 20–30:1 in western diets, which confirms higher 
omega-6 fatty acids intake [1, 71, 72] and an imbalance 
of the pro-inflammatory and anti-inflammatory proc-
esses in the cellular functions (supporting more of pro-
inflammatory). Food choices based on omega-3 fatty 
acids are therefore recommended to alleviate this im-
balance. The suggested doses of omega-6 to omega-3 
fatty acids are in a ratio of 4:1 to 10:1, accounting for 3 
and 0.5% of total energy intake, respectively [1, 64, 73, 
74]. 
3.2.2. Lignans 
Lignans are phenolic compounds composed of cin-
namic acid present in cell wall of higher plants. Lig-
nans are phytoestrogens and can also exhibit antioxi-
dant properties [1, 75, 76]. Lignans are all over the 
vegetal kingdom, mainly in fiber-rich plants, vegeta-
bles (broccoli, garlic, asparagus and carrots), fruits, 
cereals (wheat, barley and oats), beans(lentils and soy-
bean), as well as in berries, alcoholic beverages and 
also tea [1, 77]. In comparison to other plant foods, flax 
has 800 times more lignans [5]. The major lignan of 
flaxseed is secoisolariciresinol diglycoside, but it also 
has matairesinol, pinoresinol, lariciresinol and 
isolariciresinol [1, 78-80]. In the defatted flour, the 
concentration of SDG varies from 11.7-24.1 mg/g, 
while in whole flaxseed flour it varies from 6.1-13.3 
mg/g [5, 81]. 
Acid hydrolysis of secoisolariciresinol diglycoside 
produces secoisolariciresinol (SECO). In the outer lay-
ers of the seed,secoisolariciresinol diglycoside forms a 
complex with HMGA (3-hydroxy-3 methylglutaric 
acid) residues [1, 82-84]. SDG, metabolized by bacteria 
in the colon of humans, allows the synthesis of en-
terodiol (END) and also enterolactone (ENL) [85]. In 
human body, through the gastrointestinal microflora, 
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ligands release SECO, a non-sugar moiety of SDG. 
Besides, through the hydroxylation and demethylation, 
microflora can also produce mammalian lignan-END, 
oxidizing to give ENL [41, 75, 86]. It was shown that 
Bacteroides and Clostridia release glucosyl moieties 
from SDG to produce SECO [87, 88]. Eubacterium 
lentum is responsible for dehydroxylation reaction and 
Bacteroides methylotrophicum, Eubacterium cal-
landeri, Eubacterium limosum and also Peptostrepto-
coccus productus control the demethylation reactions 
[87, 89]. Clostridia and Ruminococcus sp are responsi-
ble for the dehydrogenation of END into ENL, being 
eliminated in faeces or assimilated by the human colon 
and go into the circulation [87, 90]. 
    
Secoisolariciresinol diglycoside (SDG) Matairesinol 




Fig. (1). Chemical structure of lignans existent in flaxseed. 
3.2.3. Dietary Fibers 
Worldwide, flax fibers are one of the oldest fiber 
crops. Total flax plant accounts for 25 % seed and 75 
% stem and leaves, being its fiber obtained from the 
skin of the stem of the plant [91]. The non-seed parts 
corresponding to 20 % fiber, can be removed either 
chemically or mechanically. A flax fiber, biodegrad-
able and natural composite, has low density and advan-
tageous mechanical properties. It looks like blonde 
hair, thereby called “flaxen”, as well as it is flexible, 
lustrous and soft. It is less elastic compared to cotton 
fiber, but it is also stronger [40]. 
Flaxseed is one of the best oilseeds, mainly because 
of the existence of mucilage located in outer layers of 
the seed, being an excellent source of soluble and in-
soluble dietary fibers [40, 43]. Flaxseed mucilage has 
excellent functional properties as well as health bene-
fits [1]. It has a percentage of fiber of 35–45, among 
which one third is soluble (mucilage of seed coat ) and 
two-third is insoluble fiber (cellulose, hemicellulose or 
lignin) [41, 92, 93]. Soluble fiber is composed of 
water-soluble polysaccharides and its purity and recov-
ery is depending on the extraction conditions. The 
presence of polysaccharides in the seed coat allows the 
high water binding capacity of flaxseed mucilage 
(1600-3000g of water/100g of solids) [5, 94, 95]. Mu-
cilage of flaxseed contains acidic polysaccharides (L-
rhamnose, L-fucose, L-galactose and also D-
galactouronic acid) as well as neutral polysaccharides 
(L-arabinose, Dxylose, D-galactose and also arabi-
noxylan), which functionally has identical properties to 
guar gum [95, 77]. It is known that the mucilage can be 
removed through the water and exhibits advantageous 
foam-stability properties [96].  
The dietary fiber of flaxseed is fermented by colonic 
microflora when reaches the large intestine, originating 
short-chain fatty acids (SCFA), methane, hydrogen and 
carbon dioxide, biomass, as well as laxative effects. 
Due to the bulking effect of soluble and insoluble fi-
bers, there is an increase dry and wet weight of the co-
lon contents and faeces. Through the binding capacity 
of macromolecules either enhancing the mass of mi-
crobial cells, the soluble fiber increases water binding. 
Some works showed that the contribution of soluble 
fiber to faecal weight was the same [1, 97]. On the 
other hand, there is an enhancement of the viscosity of 
intestinal contents and a delay of gastric emptying and 
nutrient uptake with the water-binding capacity of flax-
seed insoluble fiber occurring at pH 6–8 (pH environ-
ment in human intestines) [1, 77]. Thus, in order to in-
crease daily fiber intake of soluble and insoluble fiber 
(1 and 3 g respectively), it is necessary to consume 10 
g of flaxseed daily [98]. 
3.3. Nutritional Composition of Flaxseed 
Some factors, such as genetics, growing environ-
ment and also processing conditions, modify the 
chemical composition of flaxseed [41]. Lipid content 
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varies from 37-45g/100g of the seed [1, 41, 99, 
100].The main seed oil storage tissues that contain 75% 
of the oil are cotyledons [1, 40, 43, 46].Flaxseed oil 
contains about 98 % phospholipids, triacylglycerols 
and only 0.1 % of free fatty acids. Protein content ac-
counts21%, which it is concentrated in the cotyledons 
[1, 101, 102]. Globulin (26–58%) and albumin (20–
42%) are their main protein fractions, also 
containingarginine, aspartic acid and glutamic acid in 
large quantities, but lysine is present in reduced quanti-
ties [1, 40, 43, 103]. It has a large amount of cysteine 
and methionine, which offers antioxidant activity [1, 
44]. It is known that the protein content is affected by 
processing conditions, dehusking as well as defatting, 
having these latter higher protein content [1, 45, 104]. 
Flaxseed contributes very little to total carbohydrates 
intake, as it is rich in phytoestrogens and has decreased 
levels of carbohydrates (1g/100g) [1, 41]. It also has 
many phenolic compounds (phenolic acids, flavonoids 
and lignans), mainly ferulic acid (10.9 mg/g), chloro-
genic acid (7.5 mg/g) and also gallic acid (2.8 mg/g), 
offering anti-oxidant and anticancer properties. Al-
though in low quantities, it also possesses p-coumaric 
acid glucosides, hydroxycinnamic acid glucosides and 
4-hydroxybenzoic acid [1, 105, 106]. The main flavon-
oids present in flaxseeds are flavone C- and O-
glycosides, which are a good source of minerals, such 
as phosphorous (650mg/100g), magnesium (350–
431mg/100g), calcium (236–250mg/100g), sodium 
(27mg/100g) and potassium (5600–9200mg/kg) [1, 41, 
100, 106]. Besides, it also has low quantities of water-
soluble and fat-soluble vitamins, e.g. γ-tocopherol 
(39.5 mg/100 g) [1, 41, 107]. 
3.4. Anti-Nutrients from Flaxseed 
Despite its functional elements, flax also has anti-
nutritional elements that may have adverse effects on 
human health [1, 5]. The main anti-nutrients present in 
flax are cyanogenic glycosides (CGs) (250–550 
mg/100g), which are fractionated into linustatin (213–
352mg/100g), neolinustatin (91–203mg/100g), and li-
namarin (acetone–cyanohydrinbeta–glucoside 
C10H17O6N) in small amounts (32mg/100g), its con-
tent depends on the farming conditions and place [1, 
108, 109]. In comparison to seed type, the fiber type 
linseed has a high percentage of glycosides, being the 
ripe seed the one that contains less glycoside [1, 40, 
43]. Cyanogenic glycosides release hydrogen cyanide 
by intestinal β-glycosidase that produces thiocyanates, 
Table 3. Chemical and nutritional composition of flax-
seed (Adapted from [1, 5]). 
Nutrients Amount per 100g of flaxseed 
Moisture 6.5 g 
Protein 20 g 
Total Fats 41 g 
Minerals 2.4 g 
Crude fiber 4.8 g 
Total dietary fiber 28 g 
Carbohydrates 29 g 
Energy 530 kcal 
Potassium 750 mg 
Calcium 170 mg 
Phosphorous 370 mg 
Iron 2.7 mg 
Vitamin A 30 µg 
Vitamin E 0.6 mg 
Thiamine (B1) 0.53 mg 
Riboflavin (B2) 0.23 mg 
Niacin	 3.21 mg 
Pyridoxin	 0.61 mg 
Pantothenic acid	 0.57 mg 
Biotin	 0.6 µg 
Folic acid	 112 mg 
Linolenic acid	 23 g 
Ligans	 10-2.6 mg 
Ascorbic acid	 0.5 mg 
Table 2. Functional properties of flaxseed constituents 




Mucilage Emulsifier and stabilizer in sauces, sausages, 
meat emulsions and salad dressings 
Anti-staling agent in baked products  
Improves cooking quality of noodles  
Functional food ingredient  
Protein Stabilizer and emulsifier in ice cream, sauces and 
meat emulsions  
Antifungal property  
Viscoelastic texture to extruded pastes for break-
fast cereals and snacks  
Enhances nutrition in gluten free meal  
Egg and gelatine substitute in baked goods and 
ice cream  
Functional food ingredient 
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interfering with iodine uptake by the thyroid gland and 
negatively influencing iodine-deficiency disorders, goi-
ter as well as cretinism. They are heat labile and can be 
demolished through the processing methods (pelleting, 
microwave roasting or autoclaving), as well as through 
some detoxifying enzymes (β-glycosidases) that liber-
ate hydrogen cyanide, can be evaporated through the 
use of steam [1, 63, 110, 111]. Park et al. related 
207/100g seed of linustatin and 174mg/100g seed of 
neolinustatin in flaxseed. β-glucosidases are activated 
and allow the release of poisonous hydrogen cyanide 
(HCN) after seed damage [112]. Phytic acid, another 
anti-nutrient of the flaxseed, ranges from 23-33g/kg of 
the flaxseed meal [1, 113, 114]. This acid compromises 
the uptake of some nutrients (magnesium, iron, zinc, 
calcium as well as copper), which make it a powerful 
chelator, allowing the formation of protein and min-
eral-phytic acid complexes. It also decreases the 
bioavailability of micronutrients, however, some recent 
works have shown that this acid has hypocholes-
terolemic and hypolipidemic, as well as antioxidant and 
anticancer effects [1, 106, 115]. Flaxseed meal also 
contains 10mg/100g linatine (gamma-glutamyl- 1-
amino-D-proline), inducing vitamin B6 deficiency 
[106]. Ratnayake et al. did not report any effect on the 
Zn status when rats were flaxseed fed [116]. Ratnayake 
et al. and Dieken showed that in flaxseed, a vitamin B6 
antagonist (linatine) do not affect vitamin B6 contents 
or metabolism with a meal until 50 g of ground flax-
seed per day [116, 117]. Ganorkar and Jain reported 
that in comparison to soybean and canola, flaxseed 
anti-nutrients have less negative effects on human 
health [118]. Bhatty reported the presence of trypsin 
inhibitors in flaxseed, however, in comparison to soy-
bean and canola seeds, their activity has no signifi-
cance[119]. 
3.5. Uses of Flaxseed - Diet with Linseed Oil and Its 
Effects 
Flaxseed reappeared as a stronger functional ingre-
dient with many medical benefits and it is utilized in 
many classes of food products. Flaxseeds have many 
versatile uses, mainly due to the fact that all parts of 
linseed plant can be used and their supplemented food 
products are enhancing popularity [1]. The oil of the 
seed is refined and then used in food, as whole flax-
seed, ground meal as well as extracted oil or mucilage. 
It can be incorporated as nutritional additives in ready 
to eat cereals and baked cereal products, fiber bars, 
bread and muffins, salad toppings, meat extenders as 
well as spaghetti [40, 43]. The fibers that are produced 
by the stem exhibit durability and strength. Since an-
cient times flaxseeds are being consumed; seeds can be 
roasted and milled and their oil can be applied in many 
food formulations (micro- and nano-encapsulated pow-
der, neat oils and also stable emulsions). It has also 
been cultivated for fiber, medicinal purposes and nutri-
tional products [5, 73]. The fatty acids that are ab-
sorbed by the small intestine differ from those available 
in the diet, due to the extensive biohydrogenation that 
can be prevented by chemical treatments (by heating or 
by feeding whole oilseeds and also with formaldehyde) 
[55, 120]. 
The high benefits of linolenic acid at the health 
pushed forward scientific research in many fields. 
Many researchers, nutritionists and food technologists, 
as well as plant breeders, are applying molecular and 
conventional approaches in order to modify the fatty 
acid profile of flaxseed [1]. 
3.5.1. As an Ingredient 
The ability to incorporate flax-based fatty acids into 
milk and meat gives a chance to make a value-added 
product with good benefits to health. It is accepted that 
contemporary human nutrition lacks in omega-3 fatty 
acids but it is abundant in omega-6 fatty acids and satu-
rated fats. A diet abundant in omega-6 and poor in 
omega-3 fatty acids increases the mortality rate, as it 
favours clotting, vasospasm, as well as vasoconstriction 
[33, 55]. For example, around 15 g of milled flaxseed 
with about 45 mL of water can replace an egg, besides 
taking advantage of the absence of cholesterol in flax-
seeds [121]. In the case of salad dressings, flaxseed 
gum can be used in order to stabilize the emulsion [1, 
122]. Due to the ALA content, flaxseed provides 
omega-3 fatty acids that can modify milk and meat fat 
profiles. Scollan et al. showed that through the feed, 
whole bruised flaxseed can enhance the omega-
6:omega-3 ratio in meat and adipose lipid profiles 
without altering the muscle fatty acid content [123]. 
Flaxseed products are stable at ambient temperature, 
which has been by some studies that show that store the 
milled flaxseed did not change the quality [40, 43]. 
Petit et al. fed cows with whole flaxseed and also 
showed a change in the ratio for milk fat [124]. In order 
to increase the nutritional quality of the meat and eggs 
rich in omega-3 and pork products, the flaxseed was 
included in the feed for animals [125]. In the bakery 
sector, with the purpose to satisfy customer demands, 
flaxseed was mixed with grain bread and the flaxseed 
oil was also introduced into milk and dairy products, 
pasta products and macaroni, dry and beef patties, 
juices, muffins and also baked foods, making them 
ideal foods for the daily consumption [5, 126]. With 
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various studies evidencing the advantages of food 
products rich with flax, few studies shown neutral 
health impacts and less sensory acceptability. Ram-
charitar et al. showed that muffins with milled flaxseed 
were less acceptable than the control [127]. It was also 
related that Pretzel type yeast bread containing flax was 
also less acceptable in comparison to the control [128]. 
The most interesting benefit of milled flaxseed to be 
applied in bakery products is the fractions of carbohy-
drate and protein. It has been shown that flaxseed in-
creases viscosity, improves absorption and characteris-
tics of bread, stabilizes foam and protein-based emul-
sions, changes shear rate as gum arabic does, and can 
also be used as a “food thickener” and “enhancing 
agent” in baked goods [100, 129]. Hall et al. used flax-
seed particles in bread in order to obtain the good qual-
ity of the products [130]. Mentes et al. reported that the 
use of ground flaxseed can enhance loaf volume and 
Dallman degree, as well as retarded bread staling [131]. 
Hao and Beta have shown an enrich phytochemical 
profile of the bread and improve antioxidant activity 
through the incorporation of flaxseed hull into Chinese 
steamed bread (CSB) [132]. Lipilina and Ganji devel-
oped bread with flaxseed flour and also observed that 
such flour can enhance linolenic acid and dietary fiber 
[133]. Minker et al. reported the promising industrial 
use by showing that linseed mucilage has emulsifying 
properties, Arabic gum, and tragacanth gum [134]. Due 
to the high mucilage content, flaxseed exhibits a high 
capacity for water absorption, lubricity and also mois-
ture-binding capacity, allowing the production of 
throughput and puffing during extrusion processing or 
being an alternative to trans-fat free shortening in foods 
where the water absorption affects the mixing time and 
dough-handling attributes [135]. It was shown that the 
bread made with the flaxseed oil cake has lower perox-
ide levels than the threshold limits of storage [136]. An 
important characteristic is that flaxseed no contains 
gluten, being beneficial to gluten-intolerant humans. 
Thus, part of the flour can be replaced by whole or 
ground flaxseed in muffin and pancake, as well as 
bread and cookies [137]. Therefore, the involvement of 
flaxseed in food, once models the fatty acid profile of 
the human's diet is evident [55]. 
3.5.2. As An Edible Oil 
As said before, flaxseed oil is abundant in alpha-
linolenic acid. In the old days, flaxseed was useful in 
the fabrication of paints or printing inks, coating as 
well as drying oil. Recently, it is used for edible pur-
poses due to its nutraceuticals values [1]. When it is 
meant for edible purposes, due to its characteristics, 
fresh flaxseed is extracted through cold pressing [138, 
139]. Its high amount of alpha-linolenic acid has also 
disadvantages, flaxseed oil is easily oxidized, being 
susceptible to rancidity and has also poor sensory qual-
ity [140, 141]. These can cause chronic diseases. Some 
studies showed that high temperature changes its nutri-
tional composition, deteriorating the alpha-linolenic 
acid [138, 139]. Flaxseed oil is commonly used in 
cooking purposes and some investigations prove that 
stir-frying of flaxseed oil can reach up to 177°C with-
Table 4. Traditional and medicinal uses of various food products enriched with whole flaxseed, flax flour and flax oil 
(Adapted from [1, 5]). 
Flax form con-
sumed 
Traditional/medicinal health benefits Flax enriched food 
product	 
Flaxseed tea Useful against dyspnoea, asthma, dysphonia, bad cough and bronchitis 
Flaxseed drink Helps out constipation 
Flaxseed flour 
Used against pulmonary tuberculosis, haemoptysis, splenomegaly and stomach ulcer 
Cures inflammations of intestines and abdominal pains 
Disinfects gastrointestinal tract 
Strengthens the nervous system 
Strengthens the memory 
Good in treating the impairment of concentration 
Good in the management of age-associated distractibility 
Ensures rapid healing of wounds through external use 
Protects the skin against getting dry 
Used in eczema and psoriasis diseases 
Exercises a positive impact on respiratory tract diseases 
Good in curing mental disorders 
Cures bad cough 





Unleavened flat bread 
Brown bread 
Muffins and snack bar 
Cheese 
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out changing its qualities [142, 143]. In flaxseed oil, 
various components act as natural antioxidants, such as 
phenolic acids, flavonoids and lignans, among others 
[138, 139, 144]. It is also being made attempts in terms 
of encapsulation of the oil to contribute for protection 
of oxidative products that are created on processing or 
storage [145]. Aguiar et al. proved that replacing soy 
oil by flaxseed oil in bread formulations lead to en-
hanced ALA content and also decreased ratio of 
omega-6:omega-3 without affecting the quality of the 
product [146]. Ivanova et al. proved that flaxseed addi-
tive can obtain a better butter at the level of flavor, 
odor, color as well as spreadability and plasticity [147]. 
Giroux and Matumoto-Pintroa et al. developed dairy 
beverages that were rich with linseed oil, improving 
oxidative stability [148, 149]. Cloughley et al. showed 
that when laying hens were fed with a special flax diet, 
eggs were rich in omega-3. Other products are also rich 
in omega-3 when the flax is included in animal feed, 
such as pork [150]. 
3.6. Diseases and Health Benefits of Linseed Protein 
and Oil 
Besides the nutritional benefits, flaxseed has also 
other health benefits because of its components that act 
as anti-oxidants and as phytoestrogens. Some studies 
showed various techno-functional properties and bene-
fits of flaxseed proteins [5]. Benefits of flaxseed pro-
tein in coronary heart and disease, as well as in cancer 
have been described [151-153]. Flax protein is abun-
dant in glutamine and also arginine, which allows the 
prevention, as well as treatment of heart disease and 
also helps in supporting the immune system [154, 155]. 
Flaxseed is composed of bioactive peptides that have 
strong immunosuppressive and antimalarial activities 
[156]. Some studies showed that flaxseed proteins are 
very useful for therapeutic uses [157, 158]. Other stud-
ies demonstrated that a peptide mixture from flaxseed 
with increased branched-chain amino acids and also 
decreased levels of aromatic amino acids has 
antioxidants and antihypertensive properties [159]. 
Omega-3 fatty acids’ health benefits have been shown 
useful for many disorders, such as cancer, diabetes, 
also exhibiting anti-arrhythmic and anti-atherogenic, as 
well as anti-inflammatory, improving vascular function 
[5]. 
3.6.1. In Treatment of Diabetes Mellitus 
Cardiovascular diseases can be caused by an en-
hanced blood sugar. Diabetes is identified by hypergly-
cemia being also related to changes in the metabolism 
of carbohydrates, proteins and also lipids, leading to 
adverse effects [160, 161].The quantity of patients with 
diabetes has been increased exponentially in the latest 
years. If not treated, diabetes can develop into cardio-
vascular diseases, kidney failure as well as blindness 
[162]. Diabetes develops together with other risk fac-
tors, such as obesity, hypertension and low HDL cho-
lesterol, as well as high triglyceride levels. The compo-
nents of flaxseed exhibit a protective effect on diabetes 
risk [5]. Prasad reported that flaxseed lignan SDG can 
inhibit expression of the gene that is responsible for 
glucose synthesis in the liver [163]. It was shown that 
in patients with T2D, the supplementation of diet with 
flaxseed decreased fasting blood glucose and also gly-
cated hemoglobin [160]. This can be explained by the 
less content of glycemic carbohydrates and also by the 
abundance of dietary fibers of flaxseed. Some studies 
have shown a decrease in postprandial blood glucose 
levels in women that consume flaxseed [63, 164]. Kel-
ley et al. used rats predisposed to obesity and diabetic 
tumors and observed a reduction in glycaemia when 
conjugating linoleic acid and flax oil in their diet [165]. 
Kapoor et al., while studying the effect of supplemen-
tation with flaxseed powder on diabetic human fe-
males, have shown the decreased postprandial blood 
glucose levels [166]. Nazni et al. reported similar re-
sults, diabetic subjects have showed decreased blood 
glucose levels when the supplementation was made 
with flaxseed powder [167]. Dodin and Barre et al. did 
not report any change of glucose and insulin levels af-
ter ingestion of flaxseed [168, 169]. Other studies also 
showed that the use of flaxseed for glycemic control 
can also reduce the risk of obesity and dyslipidemia 
[170, 171]. 
3.6.2. Tumor and Cancer Reducing Effects 
It was suggested that flaxseed, because of the high 
level of phytoestrogen lignans and -linolenic acid-rich 
oil, has anticancer effects [172]. There is a relationship 
between flaxseed ingestion and risk of cancer. Some 
researches reported that flaxseed can inhibit the forma-
tion of colon and lung tumors and decrease blood ves-
sel cell formation in female rats, showing a protective 
effect on breast, colon and also ovarian cancer [173]. It 
was shown that elevated levels of insulin and insulin-
like growth factor 1 (IGF-1) also enhanced cancer risk 
[174].It has also been proven that insulin is related to 
the risk of pancreatic and colorectal tumors [175]. 
Other works report that adding flaxseed in fed can de-
crease the levels of insulin and IGF-1 [176, 177]. Stur-
geon et al. showed, however, that incorporation of 
flaxseed in the diet of healthy postmenopausal women 
has a smaller effect on blood levels of IGF-1 [174]. 
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Mainly due to its elevated content of SDG lignan, flax-
seed has a reduction effect on a breast tumor [173, 177-
181]. From flax lignans, enterodiol (ED) and enterolac-
tone (EL) are produced in an animal body. As they are 
identical to human estrogen-17β-estradiol (E2), they 
can bind to estrogen receptors (ER) [182]. Flaxseed 
and its SDG component can influence tumorigenesis 
[178, 179]. The protective effect of flax lignans on 
breast cancer can be explained by decreased estrogenic 
activity as well as antioxidant properties. Flaxseed oil 
also proves to decrease the human estrogen receptor-
positive breast tumors (MCF-7) growth [183]. Chen et 
al. related that the groups of mice that have been fed 
with flaxseed can avoid tumor growth [85]. Some re-
searchers proved that flaxseed helps to limit early 
stages of cancer, as well as alter estrogen metabolism 
[109, 184]. In vitro, animal, observational and clinical 
studies were conducted on flaxseed and its components 
in order to evaluate the reduced cancer risk. Almost all 
studies in diverse rodent models and also clinical trials 
showed that the intake of flaxseed can decrease the 
tumour growth, mainly breast cancer [172]. 
3.6.3. Prevention of Kidney Diseases 
Chronic kidney disease (CKD) commonly requires 
dialysis or transplantation for patients’ survival and can 
eventually lead to dead [185, 186]. It has been reported 
that, because of their anti-inflammatory properties, 
omega-3 fatty acids can also preserve kidneys. The in-
gestion of PUFAs proved to decrease renal inflamma-
tion and also fibrosis in animal models [187]. When 
rats had a fed with a high-fat diet, ALA showed anti-
inflammatory effects and decreased levels of plasma 
CRP [48]. Gopinath et al. observed that the ingestion 
of long-chain omega-3 PUFAs was opposite to the 
prevalence of CKD [188]. Cicero et al. also proved that 
the ingestion of omega-3 fatty acids was related to a 
decrease in systolic and diastolic blood pressure. This 
supplementation can be a good mechanism to protect 
the kidneys since a risk factor for CKD is hypertension 
[189]. Gopinath et al. showed a relationship between α-
linolenic acid and CKD [188]. Wang et al. tried to ex-
plain the cardioprotective results, showing that they can 
be due to the limited conversion of α-linolenic acid in 
EPA and DHA [190]. It was also shown that flaxseed 
fibers consumption can decrease the lipid uptake, by 
limiting re-uptake of bile acids that enhance hepatic 
synthesis of bile acids and also limit the formation of 
micelles [191]. 
3.6.4. Reduction of Dyslipidemia and Cardiovascular 
Diseases (CVD) 
Cardiovascular disease (CVD) is the leading cause 
of mortality worldwide. The risk factors of CVD are 
directly related to serum lipid profile. The supplemen-
tation of flax in diet was intensely investigated in ani-
mals and humans. Works made with flaxseed and its 
components have shown positive effects [192, 193]. 
CVD and its risk factors have a common characteristic 
which is inflammation [194]. The changes of inflam-
mation can be measured by C-reactive protein (CRP) 
levels [48, 195, 196]. In studies performed in rats, mice 
and also in rabbits, the effects of flaxseed on risk fac-
tors for CVD were described, showing hypocholes-
terolemic activity of flaxseed due to its lipid content 
[160, 197-203]. Gillingham et al., on the other hand, 
reported that after the consuming of flaxseed oil, 
decreased levels of high-density lipoprotein (HDL) 
fraction in human serum was observed [204]. No 
changes in HDL fraction in animals were also reported 
in different studies[192, 205, 206]. Mohamed et al. re-
ported that type 2 diabetic patients fed with flaxseeds, 
have a reduction of plasma glucose, enhancement in 
plasma lipid profile and also decrease lipid peroxida-
tion [207]. Jennifer et al. showed that fed with flaxseed 
can protect ischemic heart disease, enhancing vascular 
relaxation responses and inhibiting the ventricular fib-
rillation [208]. Vedtofte et al. did not report any rela-
tion with intake of ALA and the risk of ischemic heart 
disease [209]. Dietary factors have been playing a car-
diovascular protective role based on evidences from 
randomized controlled trials (RCTs). Reducing the in-
flammation can reduce the risk of CVD [48]. Flaxseed 
is capable of reducing the risk of cardiovascular disease 
through the decrease of lipid profile parameters, plasma 
trans fats as well as atherogenicity, glycemia or pro-
inflammatory oxylipins. They have also been related to 
blood pressure (BP) reduction [50, 210]. These hy-
potensive effects can be due to the synergistic action of 
potent antioxidants or different ingredients. A decrease 
of systolic BP (SBP) and diastolic BP (DBP) was ob-
served with flaxseed powder oil preparations, which 
observe differences between the flaxseed supplement 
and blood pressure (BP), attributed to the different 
qualities of flaxseed supplements [50]. 
3.6.5. Prevention and Treatment of Obesity 
Plant materials, including flax, allow to treat and 
prevent obesity-related disease conditions [40, 211]. 
Flaxseed fibers after hydration are capable to create 
viscous solutions that allow the suppression of hunger 
and delay gastric emptying and nutrient absorption 
from the small bowel [197, 212, 213]. In obesity, leptin 
is present at high levels [214]. McCullough et al. ob-
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served an enhanced plasma and adipose levels of ALA 
with the intake of flaxseed. Modifications on the ex-
pression of leptin were related to adipose ALA levels 
and also with risk of atherosclerosis [215]. When in-
gested as flaxseed oil, a higher bioavailability of ALA 
was observed, decreasing with the ingestion of whole 
seed. [50]. 
3.6.6. Natural Treatment of Bowel Syndrome 
Constipation can also be a serious health problem, 
which can be prevented/treated with dietary fibers [77]. 
Flaxseed fibers can act as dietary fiber, being the first 
line of treatment for constipation. Cunnane et al. re-
lated the influence of ingestion flaxseed on several in-
dices of nutrition [164]. Dietary fiber slows down gas-
tric emptying, control glucose levels, as well as coop-
erates in the prevention of constipation. Kristensen et 
al. showed the effect of flax fibers on the fat excretion, 
as well as on the energy balance. They showed that 
drinks rich with flax fiber can decrease cholesterol lev-
els in comparison to bread also rich with flax fiber but 
the ingestion of bread enhanced fecal fat excretion and 
also maintained an appropriate energy balance [1, 216]. 
Some works have described the effects of flax fiber, 
including gastrointestinal (GI)-motility, constipation, 
glucose tolerance and hypocholesterolemic effect, as 
well as fermentation [5, 160, 197]. 
3.6.7. Implication in Bone Health 
Omega-3 PUFAs also benefit bone. Some works 
reported no improvements on osteoporotic bones in 
humans and animals with the intake of whole flax-
seeds, but its combination with estrogen therapy had an 
extra benefit to the bone in animal models. The same 
results were reported with flaxseed oil, but this role 
was better on other pathologic conditions which in turn 
result in enhanced bone properties. The bone-protective 
effect is due to ALA content of flaxseeds and not the 
lignin fraction. As said before, PUFAs have an advan-
tageous role in inflammatory diseases, which include 
bone disorders. The fed with flaxseeds or flaxseed oil 
in older adults has a marginal benefit to the bone, 
mainly through the inhibition of bone resorption. In 
animals, the supplementation with flaxseed/oil en-
hanced lipid profiles in plasma, bone and also in other 
tissues. This increased bone properties in mature ani-
mals are however not shown in growing animals. The 
positive role of flaxseed/oil enhanced bone strength in 
animals with secondary osteoporosis that can be used 
as a dietary supplement in those conditions. It is clear 
that the use of flaxseed oil can be beneficial for bone 
health, mainly to osteoporosis' patients and those with 
diseases that cause bone loss. Besides the reported 
benefits, there is still a need to understand if or how 
ALA regulates bone metabolism [217]. 
4. FLAX: A NUTRACEUTICAL OR FUNC-
TIONAL FOOD? 
Nutraceutical and functional foods are incorrectly 
referred to be the same because there is a difference 
between them. Compared to a conventional food, a 
functional food having the same appearance, is part of 
the diet and has physiological benefits or to decrease 
the risk of chronic disease. Functional foods above 
their nutritional value contribute to a specific health 
benefit to the consumer and many examples derive 
from vegetal origin food [1, 5]. On the other hand, a 
nutraceutical is extracted or purified from foods that 
are not associated with foods, being sold in medicinal 
forms. It can be a part of functional foods, but a func-
tional food has to contribute to essential nutrients and 
also with qualities necessary for normal maintenance, 
growth as well as development [5]. Nutraceuticals are 
nowadays attracting growing interest for their potential 
use a toolbox to prevent and, in some cases, cure some 
pathological conditions, e.g. dyslipidemia. While 
pharmaceuticals have specific legislation on produc-
tion, efficacy and safety, as well as use in therapy to be 
validated by clinical trials, before being put on the 
market, nutraceuticals are considered to belong to food 
supplements and these rules many times are not fol-
Table 5. Biological and functional properties of flaxseed 
proteins (Adapted from [5]). 
Function of 
flax protein 
Effects and Mechanism 
Antifungal Act against food spoilage fungi Penicillium-
chrysogenum, Fusariumgraminearum and 
Aspergillusflavus 
Antioxidant Hydrolyzed flaxseed proteins exhibited anti-
oxidant property by scavenging 2, 2-diphenyl-
1- picrylhydrazyl radical, superoxide radical 
and hydroxyl radical 
Antihyperten-
sive 
Inhibits angiotensin I-converting enzyme 
Cholesterol 
lowering effect 
Due to their bile acids binding activity 
Anti-diabetic Flax proteins can interact with fiber and muci-
lage 
By stimulating the secretion of insulin 
Anti-thrombic Flax proteins - hirudine and linusitin 
Anti-tumor Presence of low lysine/arginine ratio 
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lowed. There is a lack of regulation regarding nutraceu-
ticals since they should have proven advantageous ef-
fect as a requirement before being authorized and mar-
keted. To fill this gap, there was a redefinition of the 
concept of nutraceuticals in order to differentiate them 
of food supplements, functional foods as well as from 
pharmaceuticals. The clinical test should be performed 
to assess their safety of use, efficacy and ability to pro-
vide beneficial health effects in particular for patients 
not eligible for the conventional pharmacological ther-
apy [218-220]. Flax, consumed in diverse forms, is 
considered a functional food attributed to its several 
health benefits [5, 221]. Various stable preparations of 
flax (oils, capsules and also microencapsulated pow-
ders) are available in the market in the form of nu-
traceuticals. As a dietary supplement, flax lignans-
isolated SDG preparations are also in the market [222]. 
In ancient times, flaxseeds had already been used as a 
cough remedy and also to alleviate abdominal pain. 
Food science and technology researchers are designing 
a framework for food-based dietary recommendations 
to obtain optimal nutrition through the intake of healthy 
foods in diverse areas (e.g. food physics, methods of 
food storage and preservation, nutrient restoration, for-
tification of foods, as well as the development of 
health-focused designer foods and also functional 
foods). Flaxseed has drawn the attention of scientists, 
researchers and industry due to their contents, the fact 
that it is a rich source of ALA, dietary fibers, as well as 
high-quality proteins, antioxidants and lignans, offering 
synergistic health benefits. Flaxseed can be used due to 
its various nutraceuticals and therapeutic attributes, 
making it an advantageous value-added food ingredi-
ent. Flax almost has no digestible and glycemic carbo-
hydrates. It contributes to a model for whole grains or 
seeds and highlights the recognition given to the nutri-
tional value of “whole grains”, “whole seeds” as well 
as “whole foods” [5]. A strengthening consumer de-
mand for foods enhancing health and wellbeing is re-
cent, making functional foods also a recent area of re-
search [1]. 
CONCLUSION AND FUTURE PERSPECTIVES 
In the last few years, the popularity of flax as a food 
ingredient has increased especially due to its high con-
tent of ALA. Important for brain function, essential 
fatty acids have shown to reduce “bad” cholesterol and 
to mitigate the risk of heart diseases amongst other 
health benefits. The high level of unsaturated fatty ac-
ids makes it also attractive for industrial applications in 
stains, paints and linoleum flooring. As demonstrated 
by clinical trials, flaxseed can contribute to prevent 
diseases, which enhances the design of new branded 
healthy and functional foods using both flaxseeds and 
the oil. However, more in vivo studies are still needed 
to understand the health benefits of the constituents of 
flaxseed and also to know the amount required to in-
crease its therapeutic potential. Faster, reproducible and 
more sustainable techniques for the analysis of nu-
traceuticals are also needed. While its usage goes long 
back to ancient times, flaxseed is nowadays exploited 
as a health food source. It increases the availability of 
healthy food choices, enhancing the nutrient profile of 
foods by the reduction in the salt, sugar and also satu-
rated fat content, as well as by increasing the content of 
bioactive compounds. Worldwide market healthy foods 
are growing and in future, flax and flaxseed oil will 
choose ingredients of functional foods and nutraceuti-
cals. Omega-3 and high fiber enriched diets would be 
beneficial, thus flaxseed can be recommended as a die-
tary supplement in whole seed and ground form. Be-
sides, flax/flaxseed oil can be used in the enrichment of 
diets of animals for production of omega-3 enriched 
animal origin products. In the flaxseed, the absorption 
of nutrients is influenced by the content of cyanogenic 
glycosides, linatine and phytic acid. Although it is un-
desirable the presence of these compounds, some stud-
ies indicate that no apparent illness has been reported at 
the intake of 50 g/day. Flaxseed usage is generally rec-
ognized as safe (GRAS). FDA previously authorized 
the addition of flaxseed to foods while many govern-
mental and public health authorities recommend an 
optimal health, an increase of omega-3 fatty acids in 
diet. 
LIST OF ABBREVIATIONS 
ACE = Angiotensin I–Converting Enzyme 
ALA = α-Linolenic Acid, Omega-3 Fatty Acid 
ARA = Arachidonic Acid 
BP = Blood Pressure  
CGs = Cyanogenic Glycosides 
CKD = Chronic Kidney Disease 
CVD = Cardiovascular Diseases 
DHA = Docosahexaenoic Acid 
DPPH = 2,2-Diphenyl-1-Picrylhydrazyl Radical 
DSP = Diastolic BP 
EFAs = Essential Fatty Acids 
END = Enterodiol 
ENL = Enterolactone 
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EPA = Eicosapentaenoic Acid 
FAs = Fatty Acids 
GRAS = Generally Recognized as Safe  
HCN = Hydrogen Cyanide 
HDL = High-Density Lipoprotein 
HMGA = 3-Hydroxy-3 Methylglutaric Acid 
PUFAs = Polyunsaturated Fatty Acids 
RCTs = Randomized Controlled Trials 
RDAs = Recommended Dietary Allowances 
SBP = Systolic BP 
SDG = Secoisolariciresinol Diglucoside 
SECO = Secoisolariciresinol 
T2D = Type 2 Diabetes 
TAGs = Triacylglycerols 
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